Home › Funds › PFM Health Sciences, LP › PRAX
PFM Health Sciences, LP position in PRAX
PRAXIS PRECISION MEDICINES I · Health Care
PFM Health Sciences, LP reported holding 38,575 shares of PRAX (PRAXIS PRECISION MEDICINES I) in its Q2 2026 13F filing — a position valued at US$12.9M, representing 1.13% of its reported portfolio and ranking #31 among its reported holdings. PFM Health Sciences, LP has disclosed PRAX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's PRAX position evolved
PFM Health Sciences, LP first disclosed a stake in PRAX in Q3 2023 at 8,919,997 shares (US$15.3M). The position peaked in Q1 2024 at 477,605 shares, worth US$29.1M. Across 12 filings, PFM Health Sciences, LP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 38,575 shares valued at US$12.9M — an increase of 3,137 shares quarter over quarter.. Notable position changes include a 93% trim in Q4 2023 (shares rose 174% over the following quarter), a 60% trim in Q3 2024 (shares rose 34% over the following quarter), a 49% trim in Q4 2025 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 8.92M | $15.25M | New |
| Q4 2023 | 656.55K | $14.63M | Reduce |
| Q1 2024 | 477.61K | $29.14M | Reduce |
| Q2 2024 | 453.15K | $18.74M | Reduce |
| Q3 2024 | 183.09K | $10.54M | Reduce |
| Q4 2024 | 119.51K | $9.20M | Reduce |
| Q1 2025 | 160.87K | $6.09M | Add |
| Q2 2025 | 84.71K | $3.56M | Reduce |
| Q3 2025 | 60.58K | $3.21M | Reduce |
| Q4 2025 | 31.16K | $9.18M | Reduce |
| Q1 2026 | 35.44K | $11.42M | Add |
| Q2 2026 | 38.58K | $12.91M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRAX and 13F data
PRAX (PRAXIS PRECISION MEDICINES I) is a Health Care company. 74 other funds we track also report a position in PRAX — the largest reported positions include Jupiter Topco LLC (US$1.15B), Janus Henderson Group (US$1.11B), PERCEPTIVE ADVISORS LLC (US$681.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRAX
- Jupiter Topco LLC 3.42M sh · $1.15B · Q2 2026
- Janus Henderson Group 3.46M sh · $1.11B · Q1 2026
- PERCEPTIVE ADVISORS LLC 2.04M sh · $681.63M · Q2 2026
- BAKER BROS. ADVISORS LP 1.75M sh · $586.95M · Q2 2026
- Orbis Allan Gray Ltd 1.53M sh · $512.16M · Q2 2026
- ADAGE CAPITAL PARTNERS GP, L.L.C. 1.02M sh · $339.97M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 963.35K sh · $322.52M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 959.05K sh · $321.08M · Q2 2026
- Cormorant Asset Management, LP 640.00K sh · $214.27M · Q2 2026
- Hood River Capital Management LLC 425.17K sh · $142.34M · Q2 2026
- Vivo Capital, LLC 271.12K sh · $90.77M · Q2 2026
- Logos Global Management LP 260.00K sh · $87.05M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held PRAX?
PFM Health Sciences, LP has disclosed PRAX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is PFM Health Sciences, LP's current position in PRAX?
As of Q2 2026, PFM Health Sciences, LP holds 38.58K shares of PRAX (PRAXIS PRECISION MEDICINES I), valued at $12.91M, representing 1.13% of its reported portfolio and ranking #31.
Has PFM Health Sciences, LP been buying or selling PRAX?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in PRAX. The position peaked in Q1 2024 at 477.61K shares.
Which other funds hold PRAX?
Other major institutional holders of PRAX include Jupiter Topco LLC, Janus Henderson Group, PERCEPTIVE ADVISORS LLC, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.